US: Medical cannabis lowers health insurance premiums – study
The authors estimate national legalisation of medical cannabis could see savings of more than $16.8 billion.
24 results for “insurance”
The authors estimate national legalisation of medical cannabis could see savings of more than $16.8 billion.
Towergate Insurance and the Medical Cannabis Clinicians Society (MCCS) have extended their partnership
Richard Cupit, explains how the firm is helping to support UK doctors in prescribing medical cannabis.
The UK’s society of cannabis clinicians has secured the first master insurance policy for doctors, lowering costs and making it easier for them to prescribe. The Medical Cannabis Clinicians Society (MCCS) […]
With medical cannabis not being prescribed on the NHS, it is a potentially expensive treatment for people with various conditions, including those living with daily pain. Will insurance companies in the UK step in to plug this financial burden as they would with other medicines? Cannabis Health reports.
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Introducing The Medical Cannabis Employer Handbook
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after using a contaminated product.
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
New research sheds light on the impact of cannabis legalisation on prescription drug claims following their implementation in the US. Approval of recreational and medical cannabis laws in most US […]
The number of pregnant women using cannabis in the US has more than tripled over the last two decades, with researchers calling for further studies to inform intervention approaches. Cannabis […]
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary.
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and […]
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
The majority of doctors can now prescribe for reimbursement without prior approval of the health insurance companies.
94% reported they consume cannabis for at least one medical or health reason.
Despite the positive progress, the draft list of qualifying conditions does not yet include Post-Traumatic Stress Disorder (PTSD).
The proposed changes are set to have a major impact on the country’s already booming market.
Medical cannabis associations have called for the approval requirement to be scrapped for all conditions.
Opponents of the bill have been accused of delaying the final vote.